Skip to main content

Security report for tevapharm.com

Teva Pharmaceutical Company · Healthcare · N/a

Low risk. 4 critical or high findings in Security headers and SSL/TLS.

Security score

79/100

Risk levelLow

0–100, higher is better. How it is calculated

Teva Pharmaceutical Company is a leading global biopharmaceutical enterprise specializing in innovative medicines, generics, biosimilars, and consumer healthcare products. The website reflects a mature digital presence with comprehensive content targeting patients, caregivers, healthcare professionals, investors, and job seekers. The company emphasizes scientific innovation and quality medication delivery worldwide. Technically, the site employs modern JavaScript libraries, Microsoft Azure-based telemetry, and robust cookie consent mechanisms, indicating a well-maintained infrastructure. Security posture is strong with HTTPS enforcement and privacy compliance, though explicit security headers and incident response contacts are absent. The lack of WHOIS registration data raises concerns about domain legitimacy, warranting further verification. Overall, the site is professional, trustworthy, and compliant with privacy regulations, supporting Teva's market position as a healthcare leader.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching tevapharm.com

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
57
Security headers
55
Email security
88
DNS health
85
Network security
100
GDPR outside view
88
Average
79

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention tevapharm.com, from OffSeq Breach.

Total records
699
Employees
5
Customers
653
Third parties
41
Weak passwords
0%

Latest record dated 2026-04-21 · 15 subdomains affected

See the 10 newest leaked credentials

A one-off add-on to this report that lists the most recent identifier and password pairs OffSeq Breach holds for tevapharm.com.

Select it in the checkout above.

Masked preview

  • –sso.tevapharm.com2026-04-21
  • –sso.tevapharm.com2025-11-14
  • –sso.tevapharm.com2025-08-04
  • –sso.tevapharm.com2025-07-20
  • –sso.tevapharm.com2025-04-22

Breach keeps ingesting new leaks, so these numbers can grow between scans.

Open in Breach(opens in a new tab)Monitor on Breach(opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Teva operates in the healthcare sector with a focus on biopharmaceutical innovation and generics manufacturing. Its business model combines R&D pipeline development with large-scale production of generic and biosimilar medicines. The website's structure and content suggest a global enterprise targeting multiple stakeholders including patients, healthcare providers, and investors. The presence of investor relations and corporate governance sections indicates transparency and regulatory compliance. The company leverages partnerships and out-licensing to expand market reach. The digital presence supports brand trust and customer engagement, with clear navigation and rich content. However, the missing WHOIS data is an anomaly for a company of this scale and should be investigated to ensure domain authenticity.

Security posture

The website demonstrates a solid security foundation with HTTPS and cookie consent mechanisms aligned with GDPR. Use of Microsoft Application Insights and Clarity indicates active monitoring of site performance and user behavior. However, the absence of explicit security headers like Content-Security-Policy and lack of published vulnerability disclosure or incident response contacts represent gaps in security transparency. No vulnerabilities or exposed sensitive data were detected in the HTML content. The site would benefit from enhanced security best practices and clearer communication channels for security incidents. Overall, the security posture is good but can be improved to meet enterprise-grade standards fully.

Recommendations

  1. Publish explicit security headers such as Content-Security-Policy, X-Frame-Options, and Referrer-Policy to enhance protection against common web attacks.
  2. Establish and publicize a vulnerability disclosure policy or security.txt file to encourage responsible reporting of security issues.
  3. Provide clear incident response contact information (e.g., security@ or abuse@ email addresses) to improve transparency and readiness.
  4. Regularly audit and update third-party scripts to mitigate risks from external dependencies.
  5. Enhance data retention and privacy policy disclosures to increase user trust and compliance clarity.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Teva Pharmaceutical Company
Description
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. They push the boundaries of scientific innovation and deliver quality medication for millions of patients every day.
Key services
Generic Medicines, Biosimilars, Medical Information, Consumer Healthcare, Out-Licensing Generic Pharmaceuticals, Quality Products
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, Popper.js, Microsoft Application Insights, Google Tag Manager, OneTrust Cookie Consent, Clarity (Microsoft), idio Analytics
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with opt-in/out
  • Use of Application Insights for telemetry
  • Use of Microsoft Clarity for user behavior analytics
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Microsoft Application Insights, Microsoft Clarity, idio Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Microsoft Clarity, idio Analytics
Marketing tools
idio Analytics, Microsoft Clarity
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation
  2. Strong corporate branding and professional design
  3. Comprehensive cookie consent and privacy compliance mechanisms
  4. No direct contact emails or phone numbers found in the HTML content
  5. WHOIS data missing, which is unusual for a major pharmaceutical company domain
  6. Use of modern analytics and tracking technologies
  7. No security.txt or vulnerability disclosure found
  8. No explicit incident response or security contact information found
Technical notes

Notes

The website uses a modern tech stack including jQuery, Popper.js, Microsoft Application Insights, Microsoft Clarity, and Google Tag Manager, indicating a mature digital infrastructure. Hosting appears to be on Microsoft Azure, supporting scalability and reliability. The site is mobile-optimized with responsive design and accessibility considerations. Performance is moderate, with room for optimization. SEO practices are good with proper meta tags and Open Graph data. No CMS was explicitly detected, suggesting a custom or proprietary platform. The technical implementation supports a professional user experience but could benefit from enhanced security header implementation and performance tuning.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 82/100 +39Low22 findingsView report
  2. 43/100High34 findingsView report
Reviews of this site

Share your experience with tevapharm.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review tevapharm.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.